We are in Phase 2* of the Resumption of Research Phased Plan
* For principal investigators who have had a plan approved for resumption.
Email research-covid@uky.edu with questions concerning research and COVID-19 policies.
|
|
NIH Office of the Director - Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
Notice Number: NOT-OD-20-122
Release Date: July 8, 2020
Purpose: NIH grant applications should NOT include contingency plans that would outline steps needed to recover from temporary, emergency situations, or institutional return-to-the-workplace plans, resulting from the COVID-19 pandemic. |
|
New UK FAQ: Can I mandate that my employees or research participants have a negative COVID-19 test before returning to work or participating in an on-going research study?
No, you may not implement COVID-19 testing requirements that are beyond what the University and UK HealthCare requires. See the full answer, including the UK Playbook and guidelines on research participant screening. |
|
IACUC inspections to resume
IACUC site inspections will resume in accordance with Phase 3 guidelines as established by the Office of the Vice President for Research (OVPR). PIs and/or animal facility area supervisors will be contacted by email to determine the best days and times for an inspection. The Continuing Protocol Review (CPR) program will also resume in accordance with Phase 3 guidelines. Additional details will be provided at a later date. |
|
Biological Safety support
Information and updates related to COVID-19 can be found at ehs.uky.edu. EHS would like to remind all research personnel to mask up, wash your hands, and maintain physical distance while in UK facilities. UK's Playbook for operations can be found at www.uky.edu/coronavirus and contains the current guidance on the required use of masks/face coverings. |
|
DLAR Resources and use of space
Animal Orders have increased over 300% in the last week, and we have seen a considerable increase in research personnel working in DLAR. With the limitations on the number of people that can be in a room it is important to reserve rooms. If you have not done so previously, information can be found at www.research.uky.edu/reusable_files/890 or on the DLAR web page under EMS User Guide in the Quick Links box. |
|
|
|
|
|
|
|
NSF: Dear Colleague Letter: Sentinel Cells for Surveillance and Response to Emergent Infectious Diseases
There is an urgent need for novel approaches to predict or detect the emergence of new infectious diseases, including agents that have recently appeared within a population or have existed and are showing signs of rapid expansion.
Learn more →
NIH: Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
This FOA supports basic and clinical mechanistic research on SARS-CoV-2 and COVID-19 susceptibility, routes of infection, course of disease, morbidity and mortality in people with pre-existing diseases, or adverse acute or chronic outcomes, including diabetes and other metabolic diseases, obesity, and endocrine, digestive, liver, pancreas, kidney, urological, and hematologic tissues and diseases.
Closing Date: December 16, 2020
Learn more →
Fast Grants: Fast Funding for COVID-19 Science
Fast Grants are $10k to $500k and decisions are made in under 14 days. If we approve the grant, you'll receive payment as quickly as your university can receive it. We will close application submission as soon as we’ve received sufficient high-quality applications that we’re confident that our funds can be well-spent. We prioritize work that is already underway (but lacking in funding) and that is likely to yield impact within 2020.
Learn more →
USDA: Response to Novel Coronavirus (SARS-COV-2): Innovating Formal and Non-Formal Educational Experiences in Food and Agricultural Sciences During the Time of Social Distancing
This program area priority addresses the need to develop and deploy rapid, reliable, and readily adoptable strategies in workforce preparation through formal K-14 education, as well as in youth development through non-formal (extension) education to cultivate interest and competencies in STEM and agriculture during this challenging time.
Closing Date: August 20, 2020
Learn more →
|
|
|
|
|
The CARES Act was signed into law on March 27, 2020, to give financial assistance to Americans, bring relief to small businesses and workers, stabilize the economy, and support healthcare workers and patients. CARES Act funds to federal agencies are being dispersed to address the pandemic on many fronts. To date, UK has received more than $68 million from the CARES Act, including funding for UK HealthCare, the College of Nursing, the Center for Excellence in Rural Health, and the Von Allmen Center for Entrepreneurship (VACE) in the Gatton College of Business and Economics. See more on the CARES Act Research Funding and Policy.
|
|
|
|
|
|
There are three COVID-19 Unified Research Experts (CURE) Alliance teams.
PURPOSE:
- To facilitate and coordinate COVID-19 research within a given area at UK
- To align COVID-19 research in given area to funding opportunities
- To serve as a liaison both within and external to UK in area COVID-19 related research
TEAMS:
INTERNAL PILOT FUNDING:
July 13, 2020: Due to current commitments to many excellent applications, we are not accepting new applications for the UK CURE Alliance COVID Pilot Program. Availability of funds will be reevaluated in four to six weeks. Please contact Joel Thompson (joel.thompson@uky.edu) if you have any questions.
|
|
|
|
If you have general questions related to research operations during the COVID-19 pandemic or would like to report non-compliance of a laboratory or PI as it relates to the UK Resumption of Research Plan please email research-covid@uky.edu.
Below are specific contacts that provide specialized services to support our research community:
Biological Safety
Brandy Nelson, brandy.nelson@uky.edu, (859) 257-1049
Office of Sponsored Projects Administration (OSPA)
Contact your college RA or CGO, call (859) 257-9420, or visit www.research.uky.edu/office-sponsored-projects-administration
Office of Research Integrity (ORI)
rs_ori@uky.edu, (859) 257-9428
Proposal Development Office (PDO)
pdo@uky.edu
Office of Technology Commercialization (OTC)
otcinfo@uky.edu, (859) 323-1054
Office of the Attending Veterinarian
Mark Suckow, msuckow@uky.edu, (859) 257-1117 |
|
|
|
|
Contact Stacy Gaylor to manage your subscription
|
|
|
An Equal Opportunity University
|
|
|
|
|
|
|
